IL-15 downregulates CD62L expression on CD56bright NK subsets to a greater extent than on that of on CD56dim subsets from SLE patients (28.3 ± 4.7% versus 20.6 ± 3.4%, p = 0.023). Here, SELL is linked to systemic lupus erythematosus.